Hoitt Jason (CIK 1762572) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell STOK (1,033 shares), Sell STOK (748 shares), Sell STOK (1,762 shares), Sell STOK (139 shares), Sell STOK (30 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Sell | 1,033 | $33,820 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Sell | 748 | $24,968 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Sell | 1,762 | $55,115 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Sell | 139 | $4,419 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Sell | 30 | $986 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | Chief Patient Officer | Buy | 10,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-19